FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Mar. 31, 2024

Fair Value Disclosures [Abstract]

Schedule of Cash, Cash Equivalents, Investments, and Other Assets Measured at Fair Value on Recurring Basis

The financial instruments reported within Cash and Cash Equivalents in the Company’s Condensed Consolidated Balance Sheets as of March 31, 2024, and June 25, 2023 consisted of the following:

		March 31, 2024		June 25, 2023
	(in thousands)
Money market funds (fair value measured on a recurring basis, level 1)		$	2,277,989	$	2,223,642
Cash		1,693,654		2,132,522
Time deposits		1,700,589		980,892
Total		$	5,672,232	$	5,337,056